Get the Stockscreener App
87.35
14.78%
11.25
After Hours:
87.35
Prestige Consumer Healthcare Inc stock is traded at $87.35, with a volume of 758.82K.
It is up +14.78% in the last 24 hours and up +17.22% over the past month.
See More
Previous Close:
$76.10
Open:
$80.9
24h Volume:
758.82K
Relative Volume:
2.76
Market Cap:
$3.68B
Revenue:
$1.11B
Net Income/Loss:
$205.95M
P/E Ratio:
21.25
EPS:
4.11
Net Cash Flow:
$254.64M
1W Performance:
+11.39%
1M Performance:
+17.22%
6M Performance:
+28.21%
1Y Performance:
+38.87%
1-Day Range:
$79.12
$87.39
1-Week Range:
$74.35
$87.39
52-Week Range:
$60.00
$87.39
Prestige Consumer Healthcare Inc Stock (PBH) Company Profile
Name
Prestige Consumer Healthcare Inc
Sector
Phone
(914) 524-6800
Address
660 WHITE PLAINS RD., TARRYTOWN, NY
Compare PBH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PBH
Prestige Consumer Healthcare Inc
|
87.35 | 3.68B | 1.11B | 205.95M | 254.64M | 4.11 |
|
ZTS
Zoetis Inc
|
174.12 | 78.56B | 9.15B | 2.43B | 2.31B | 5.32 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.61 | 43.15B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
9.51 | 43.00B | 14.26B | 1.55B | 0 | 0.3383 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.29 | 19.59B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
150.51 | 15.24B | 2.24B | 385.90M | 440.10M | 3.73 |
Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-24 | Downgrade | Sidoti | Buy → Neutral |
| Jun-21-24 | Upgrade | DA Davidson | Neutral → Buy |
| Nov-17-22 | Initiated | Canaccord Genuity | Buy |
| May-10-22 | Upgrade | Jefferies | Hold → Buy |
| May-09-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Aug-07-20 | Downgrade | DA Davidson | Buy → Neutral |
| Jun-29-20 | Upgrade | Sidoti | Neutral → Buy |
| Apr-14-20 | Downgrade | Jefferies | Buy → Hold |
| Apr-07-20 | Resumed | Sidoti | Neutral |
| Mar-26-20 | Upgrade | Jefferies | Hold → Buy |
| Mar-24-20 | Initiated | Oppenheimer | Perform |
| Mar-19-20 | Upgrade | DA Davidson | Neutral → Buy |
| Jan-15-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Dec-04-17 | Upgrade | William Blair | Mkt Perform → Outperform |
| Jun-02-17 | Upgrade | Jefferies | Underperform → Hold |
| May-22-17 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-27-16 | Reiterated | B. Riley & Co. | Buy |
| Nov-17-16 | Initiated | Gabelli & Co | Buy |
| Aug-12-16 | Upgrade | Sidoti | Neutral → Buy |
| Mar-08-16 | Initiated | KeyBanc Capital Mkts | Overweight |
| Feb-05-16 | Initiated | Piper Jaffray | Overweight |
| Nov-30-15 | Downgrade | Jefferies | Hold → Underperform |
| Apr-28-14 | Reiterated | B. Riley & Co. | Buy |
| Apr-28-14 | Reiterated | Oppenheimer | Outperform |
| Jul-09-13 | Initiated | B. Riley & Co. | Buy |
View All
Prestige Consumer Healthcare Inc Stock (PBH) Latest News
Prestige Consumer Healthcare Reports Stable Earnings Growth - TipRanks
Prestige Consumer Healthcare anticipates FY2025 EPS of $4.5 backed by debt reduction initiatives - MSN
We Think Prestige Is Small but Mighty, Boasting Leadership in Niche Categories - Morningstar
Prestige Consumer Healthcare Shares Rise After Fiscal Q3 Results Beat Consensus - Marketscreener.com
Prestige Consumer (PBH) Banks on its Portfolio Amid Cost Woes - MSN
Prestige Consumer Healthcare: Fiscal Q3 Earnings Snapshot - Danbury News Times
Prestige Consumer Healthcare (PBH) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance Australia
Prestige Consumer Healthcare (PBH) Q3 Earnings and Revenues Beat Estimates - MSN
ForexTV | Small Business Resources - ForexTV.com
Prestige Consumer Healthcare Reports Q3 2024 Financial Growth - TipRanks
(PBH) Prestige Consumer Healthcare Forecasts Fiscal Year 2025 Adjusted EPS $4.50 - Marketscreener.com
Earnings Flash (PBH) Prestige Consumer Healthcare Reports Fiscal Q3 Revenue $290.3M, vs. FactSet Est of $286.5M - Marketscreener.com
Prestige Consumer Healthcare: Fiscal Q3 Earnings Snapshot -February 06, 2025 at 06:06 am EST - Marketscreener.com
Prestige Healthcare Crushes Q3 Expectations: Record Sales & Raised Guidance Signal Strong Growth Momentum - StockTitan
Jennison Associates LLC Lowers Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) - MarketBeat
Blue Trust Inc. Has $158,000 Stock Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
Prestige Consumer Healthcare (PBH) Projected to Post Quarterly Earnings on Thursday - Defense World
Prestige Consumer Healthcare Inc (PBH) Q3 2025 Earnings Report P - GuruFocus.com
Pacer Advisors Inc. Has $262,000 Position in Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
Boston Trust Walden Corp Increases Stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) - MarketBeat
SG Americas Securities LLC Purchases 947 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
Prestige Consumer Healthcare Inc. (NYSE:PBH) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Prestige Consumer Healthcare Inc. (NYSE:PBH) Receives $85.25 Average PT from Analysts - Defense World
Pointsbet Shares Dive Despite Positive Market Movement - Finimize
Baby Electrolyte Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2022 to 2031)... - WhaTech
Olstein Capital Management L.P. Decreases Stock Position in Prestige Consumer Healthcare Inc. (NYSE:PBH) - MarketBeat
Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Purchased by Avior Wealth Management LLC - MarketBeat
Prestige Consumer Stock Up 29.9% in a Year: What's Behind the Surge? - MSN
Prestige Consumer Healthcare (NYSE:PBH) Stock Rating Upgraded by StockNews.com - MarketBeat
Prestige Consumer Healthcare (NYSE:PBH) Upgraded at StockNews.com - Defense World
Dimensional Fund Advisors LP Reduces Stake in Prestige Consumer Healthcare Inc. - GuruFocus.com
Assenagon Asset Management S.A. Grows Stock Position in Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
Assenagon Asset Management S.A. Boosts Position in Prestige Consumer Healthcare Inc. (NYSE:PBH) - MarketBeat
US Q4 Consumer Health Earnings Preview: Executive, ‘Playbook’ And ‘Fundamental’ Changes - News & Insights
The 6.2% return this week takes Prestige Consumer Healthcare's (NYSE:PBH) shareholders five-year gains to 92% - Yahoo Finance
Zacks Research Has Bearish Estimate for PBH Q2 Earnings - Defense World
StockNews.com Downgrades Prestige Consumer Healthcare (NYSE:PBH) to Hold - Defense World
Prestige Consumer Healthcare (NYSE:PBH) Rating Lowered to Hold at StockNews.com - MarketBeat
HRG’s five notable products from December 2024 - Drug Store News
Zacks Research Brokers Reduce Earnings Estimates for PBH - MarketBeat
Zacks Research Has Bullish Estimate for PBH FY2025 Earnings - Defense World
Zacks Research Issues Optimistic Forecast for PBH Earnings - MarketBeat
Pinning Down Prestige Consumer Healthcare Inc.'s (NYSE:PBH) P/S Is Difficult Right Now - Simply Wall St
Canaccord maintains Buy on Prestige Brands stock By Investing.com - Investing.com Canada
PBH or BSX: Which Is the Better Value Stock Right Now? - Yahoo Finance
GAMMA Investing LLC Increases Position in Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
JPMorgan Chase & Co. Acquires 8,533 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Bought by JPMorgan Chase & Co. - MarketBeat
Prestige Consumer Healthcare Announces Fiscal 2025 Third Quarter Earnings Results Date and ICR Conference Presentation - The Manila Times
Prestige Consumer Healthcare Announces Fiscal 2025 Third - GlobeNewswire
Prestige Consumer Healthcare Sets Q3 Earnings Date, Plans ICR Conference Appearance - StockTitan
Prestige Consumer Healthcare Inc Stock (PBH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
0.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):